microRNA 562 (miR-562 (or hsa-miR-562 for human-specific context))

microRNA 562 (miR-562) is a member of the microRNA family, consisting of small noncoding RNAs that regulate gene expression primarily through post-transcriptional translational repression by binding to the 3′ untranslated region (3′ UTR) of target messenger RNAs[2][3]. miR-562 has been reported to directly target and inhibit expression of NF-κB1 (p105), implicating a role in modulating the canonical NF-κB pathway[3]. Experimental evidence shows that miR-562 may play a role in both wound healing and tumor-induced angiogenesis, at least in breast cancer cell line models, suggesting a possible contribution to tumor microenvironment modulation[3]. However, there is no strong evidence in the literature to support classification of miR-562 as a direct therapeutic target, enzyme, receptor, transporter, or a similar classical drug target—rather, it functions as an epigenetic gene expression regulator. Additionally, information specific to miR-562 is limited, and it is not among the most frequently studied or noted microRNAs in major disease processes or as a drug target[3].

Other names

MIR562hsa-mir-562MIRN562

Inhibition of target mRNA translation by binding 3′ UTR and downregulation of NF-κB1 (p105) expression.